OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Global Epidemiology and Genetics of Hepatocellular Carcinoma
Ming Ren Toh, Evelyn Wong, Sunny H. Wong, et al.
Gastroenterology (2023) Vol. 164, Iss. 5, pp. 766-782
Closed Access | Times Cited: 263
Ming Ren Toh, Evelyn Wong, Sunny H. Wong, et al.
Gastroenterology (2023) Vol. 164, Iss. 5, pp. 766-782
Closed Access | Times Cited: 263
Showing 51-75 of 263 citing articles:
Estrogen induces LCAT to maintain cholesterol homeostasis and suppress hepatocellular carcinoma development
Wenzhi He, Min Wang, Xuechun Zhang, et al.
Cancer Research (2024) Vol. 84, Iss. 15, pp. 2417-2431
Closed Access | Times Cited: 4
Wenzhi He, Min Wang, Xuechun Zhang, et al.
Cancer Research (2024) Vol. 84, Iss. 15, pp. 2417-2431
Closed Access | Times Cited: 4
SLC25A19 is a novel prognostic biomarker related to immune invasion and ferroptosis in HCC
Shiqi Liu, Pengjie Zhang, Yubo Wu, et al.
International Immunopharmacology (2024) Vol. 136, pp. 112367-112367
Open Access | Times Cited: 4
Shiqi Liu, Pengjie Zhang, Yubo Wu, et al.
International Immunopharmacology (2024) Vol. 136, pp. 112367-112367
Open Access | Times Cited: 4
Collagen in hepatocellular carcinoma: A novel biomarker and therapeutic target
Dongyang Ding, Shu-ya Jiang, Yun-xi Zu, et al.
Hepatology Communications (2024) Vol. 8, Iss. 7
Open Access | Times Cited: 4
Dongyang Ding, Shu-ya Jiang, Yun-xi Zu, et al.
Hepatology Communications (2024) Vol. 8, Iss. 7
Open Access | Times Cited: 4
An updated overview on hepatocellular carcinoma in patients with Metabolic dysfunction-Associated Steatotic Liver Disease: Trends, pathophysiology and risk-based surveillance
Angelo Armandi, Chiara Rosso, Gian Paolo Caviglia, et al.
Metabolism (2024), pp. 156080-156080
Open Access | Times Cited: 4
Angelo Armandi, Chiara Rosso, Gian Paolo Caviglia, et al.
Metabolism (2024), pp. 156080-156080
Open Access | Times Cited: 4
Integrated UHPLC-Q-Exactive Orbitrap HRMS and Serum Pharmacochemistry for the Investigation of Anti-hepatic Fibrosis Effect of BaoGanNing Decoction
Kaili Deng, Min Li, Liangliang Xiang, et al.
Phytomedicine (2025) Vol. 137, pp. 156363-156363
Closed Access
Kaili Deng, Min Li, Liangliang Xiang, et al.
Phytomedicine (2025) Vol. 137, pp. 156363-156363
Closed Access
DNA methylation of ACADS promotes immunogenic cell death in hepatocellular carcinoma
Ze Qian, Yifan Jiang, Yacong Wang, et al.
Cell & Bioscience (2025) Vol. 15, Iss. 1
Open Access
Ze Qian, Yifan Jiang, Yacong Wang, et al.
Cell & Bioscience (2025) Vol. 15, Iss. 1
Open Access
Prognostic impact of primary versus secondary resistance to sorafenib in patients with HCC
Lei Jin, Hongyuan Dai, Ya Zhang, et al.
Therapeutic Advances in Medical Oncology (2025) Vol. 17
Open Access
Lei Jin, Hongyuan Dai, Ya Zhang, et al.
Therapeutic Advances in Medical Oncology (2025) Vol. 17
Open Access
circCCNY enhances lenvatinib sensitivity and suppresses immune evasion in hepatocellular carcinoma by serving as a scaffold for SMURF1 mediated HSP60 degradation
Lei Yang, Wenliang Tan, Min Wang, et al.
Cancer Letters (2025) Vol. 612, pp. 217470-217470
Closed Access
Lei Yang, Wenliang Tan, Min Wang, et al.
Cancer Letters (2025) Vol. 612, pp. 217470-217470
Closed Access
Unveiling expression patterns, mechanisms, and therapeutic opportunities of transmembrane protein 106C: From pan-cancers to hepatocellular carcinoma
Jian‐Di Li, Rong‐Quan He, Yi‐Wu Dang, et al.
World Journal of Gastrointestinal Oncology (2025) Vol. 17, Iss. 2
Closed Access
Jian‐Di Li, Rong‐Quan He, Yi‐Wu Dang, et al.
World Journal of Gastrointestinal Oncology (2025) Vol. 17, Iss. 2
Closed Access
ENTPD8 Overexpression Enhances Anti-PD-L1 Therapy in Hepatocellular Carcinoma via miR-214-5p Inhibition
Siqi Zhao, Minjie Chen, Fei Chen, et al.
iScience (2025) Vol. 28, Iss. 2, pp. 111819-111819
Open Access
Siqi Zhao, Minjie Chen, Fei Chen, et al.
iScience (2025) Vol. 28, Iss. 2, pp. 111819-111819
Open Access
Identification of Hepatocellular Carcinoma Subtypes Based on Global Gene Expression Profiling to Predict the Prognosis and Potential Therapeutic Drugs
Cunzhen Zhang, Jiyao Wang, Lin Jia, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 236-236
Open Access
Cunzhen Zhang, Jiyao Wang, Lin Jia, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 236-236
Open Access
Li Bie, Guangquan Chen, Xin Gen Lei, et al.
Journal of Clinical Laboratory Analysis (2025)
Open Access
Ternary complex of Kaempferol-Hydroxypropyl-β-Cyclodextrin-Liposomes against hepatocellular carcinoma: Preparation, validation, pharmacokinetics and efficacy studies
Sunil Kumar Sah, Sama Ajay, Asawari Dilip Donadkar, et al.
International Journal of Pharmaceutics (2025), pp. 125261-125261
Closed Access
Sunil Kumar Sah, Sama Ajay, Asawari Dilip Donadkar, et al.
International Journal of Pharmaceutics (2025), pp. 125261-125261
Closed Access
Clinical Applications of Artificial Intelligence (AI) in Human Cancer: Is It Time to Update the Diagnostic and Predictive Models in Managing Hepatocellular Carcinoma (HCC)?
Mario Romeo, Marcello Dallio, Carmine Napolitano, et al.
Diagnostics (2025) Vol. 15, Iss. 3, pp. 252-252
Open Access
Mario Romeo, Marcello Dallio, Carmine Napolitano, et al.
Diagnostics (2025) Vol. 15, Iss. 3, pp. 252-252
Open Access
Sorafenib as Adjuvant Therapy Post–Liver Transplant: A Single-center Experience
Hala Hassanain, Ashton A. Connor, Elizabeth W. Brombosz, et al.
Transplantation Direct (2025) Vol. 11, Iss. 2, pp. e1746-e1746
Open Access
Hala Hassanain, Ashton A. Connor, Elizabeth W. Brombosz, et al.
Transplantation Direct (2025) Vol. 11, Iss. 2, pp. e1746-e1746
Open Access
Minimally invasive versus Open liver resection for nonmetastatic Hepatocellular Carcinoma staged BCLC - B and - C: an Italian multicentric analysis
Gianluca Cassese, Mariano Cesare Giglio, Alessandro Vitale, et al.
HPB (2025)
Closed Access
Gianluca Cassese, Mariano Cesare Giglio, Alessandro Vitale, et al.
HPB (2025)
Closed Access
Cross‐Referencing Multifluid Metabolic Profiles on Hollow Dodecahedral Nanocages for Enhanced Disease Status Identification
Fangying Shi, Lingli Chen, Yiming Qiao, et al.
Small (2025) Vol. 21, Iss. 9
Closed Access
Fangying Shi, Lingli Chen, Yiming Qiao, et al.
Small (2025) Vol. 21, Iss. 9
Closed Access
To construct and validate a risk score model of angiogenesis-related genes to predict the prognosis of hepatocellular carcinoma
Duangui Gao, Lu Yuan, Tianpeng Jiang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Duangui Gao, Lu Yuan, Tianpeng Jiang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Burden of five major types of gastrointestinal cancer in the Eastern Mediterranean Region
Saleh A. Alessy, Eileen Morgan, Ali S. Alzahrani, et al.
BMJ Open Gastroenterology (2025) Vol. 12, Iss. 1, pp. e001577-e001577
Open Access
Saleh A. Alessy, Eileen Morgan, Ali S. Alzahrani, et al.
BMJ Open Gastroenterology (2025) Vol. 12, Iss. 1, pp. e001577-e001577
Open Access
Development and Evaluation of 68Ga-Labeled TMTP1-Based Cyclic Peptide Probes for Targeting Hepatocellular Carcinoma
Yesen Li, Yanjie Wang, Yaoxuan Wang, et al.
Molecular Pharmaceutics (2025)
Closed Access
Yesen Li, Yanjie Wang, Yaoxuan Wang, et al.
Molecular Pharmaceutics (2025)
Closed Access
Causality of blood metabolites on hepatocellular carcinoma and cholangiocarcinoma: a metabolome-wide mendelian randomization study
Lin Ning, Zhanhua Gao, Di Chen, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Lin Ning, Zhanhua Gao, Di Chen, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Transforming Hepatocellular Carcinoma Treatment in Lower Income Countries
Channa R. Jayasekera, Chrishanthi Rajasooriyar, Clayton Richards, et al.
Mayo Clinic Proceedings (2025)
Closed Access
Channa R. Jayasekera, Chrishanthi Rajasooriyar, Clayton Richards, et al.
Mayo Clinic Proceedings (2025)
Closed Access
Human colonic EVs induce murine enteric neuroplasticity via the lncRNA GAS5/miR-23/NMDA NR2B axis
QiQi Zhou, Liuqing Yang, Zachary Thomas Verne, et al.
JCI Insight (2025) Vol. 10, Iss. 5
Open Access
QiQi Zhou, Liuqing Yang, Zachary Thomas Verne, et al.
JCI Insight (2025) Vol. 10, Iss. 5
Open Access
Safety and efficacy of PD-1 inhibitors plus tyrosine kinase inhibitors combination therapy in patients with advanced hepatocellular carcinoma combined with hyperbilirubinemia: a retrospective cohort study
Shida Pan, Jianing Wang, Jiahe Tian, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Shida Pan, Jianing Wang, Jiahe Tian, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
The causal relationship between eosinophil counts and hepatocellular carcinoma in East Asians: evidence from a Mendelian randomization study
Dong Liu, Jinju Xia, Ruilin He, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Dong Liu, Jinju Xia, Ruilin He, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
